Economic evaluation of tranexamic acid for the treatment of acute gastrointestinal bleeding: a cost-effectiveness analysis using data from the HALT-IT randomised controlled trial

OBJECTIVE: To perform an economic evaluation of tranexamic acid (TXA) versus no-TXA, in addition to current clinical practice, for acute gastrointestinal bleeding, using the results of the HALT-IT trial (NCT01658124), a large randomised controlled trial which included 11 937 patients. DESIGN: A cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazeer, Nuha, Miners, Alec, Roberts, Ian, Shakur-Still, Haleema, Jairath, Vipul, Williams, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301815/
http://dx.doi.org/10.1136/bmjopen-2021-060505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301815/
http://dx.doi.org/10.1136/bmjopen-2021-060505

Ejemplares similares